Mannitol (Bronchitol) for the indication 'adult patients with cystic fibrosis
The WAR has approved a pharmacotherapeutic report for the medicine mannitol (Bronchitol) capsules with dry powder for inhalation. In determining its therapeutic value, mannitol was compared with nebulised hypertonic saline. They reached the following conclusion. - due to insufficient evidence, the therapeutic value of mannitol for the treatment of adult patients with cystic fibrosis is lower than that of the existing treatment.